The pharmacology and subacute toxicology of dopamine.
Preclinical studies with dopamine showed a unique spectrum of biological activities which suggested that it might be of therapeutic use in the clinical syndromes of shock and low cardiac output. Most prominent among these were its effects on cardiac output, renal perfusion, and vital organ flow. The unique effect on renal function and the subsequent studies by Goldberg and his colleagues led to the recognition of a previously unknown catecholamine receptor site, the 'dopaminergic receptor'. Studies on the toxicology of dopamine in our laboratories suggested that dopamine could be safely used in the clinic.
D000818:Animals; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology* / Q000633:toxicity; D007262:Infusions, Intravenous; D051379:Mice; D051381:Rats; D011919:Rats, Inbred Strains; D013045:Species Specificity
D004298:Dopamine
Proc Soc Exp Biol Med. 1965 Jun;119:373-6
14328894
J Pharmacol Exp Ther. 1964 Jul;145:64-70
14209513
J Pharm Pharmacol. 1966 Apr;18(4):261-2
4381257
Br J Pharmacol. 1975 Dec;55(4):475-86
1212559
Proc Soc Exp Biol Med. 1971 Jan;136(1):268-70
5540622
Prog Cardiovasc Dis. 1969 Jul;12(1):40-51
5807585
J Pharmacol Exp Ther. 1967 May;156(2):310-24
6026261
N Engl J Med. 1966 Dec 22;275(25):1389-98
5957632
J Pharmacol Exp Ther. 1966 Jan;151(1):23-31
5902175